# MDB Capital Holdings, LLC: financial statements, quarterly

MDBH · Nasdaq · CIK 1934642 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdbh.md) · [Financials](/companies/mdbh/financials.md) · [Filings](/companies/mdbh/filings.md) · [Insiders](/companies/mdbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mdbh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | [0.0](/filings/0001493152-24-044825.md) | [0.5 d](/filings/0001641172-25-001819.md) | [0.3](/filings/0001641172-25-009686.md) | [0.2](/filings/0001641172-25-024022.md) | [0.7](/filings/0001493152-25-022351.md) | [0.2 d](/filings/0001493152-26-013924.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(3.3)](/filings/0001493152-24-044825.md) | [7.9 d](/filings/0001641172-25-001819.md) | [(0.7)](/filings/0001641172-25-009686.md) | [2.3](/filings/0001641172-25-024022.md) | [(0.6)](/filings/0001493152-25-022351.md) | [1.1 d](/filings/0001493152-26-013924.md) | [0.8](/filings/0001493152-26-023080.md) | [(1.9)](/filings/0001493152-26-037742.md) | [1.3](/filings/0001493152-25-022351.md) | [4.7 d](/filings/0001493152-26-013924.md) | [0.0](/filings/0001493152-26-023080.md) | [(0.6)](/filings/0001493152-26-037742.md) |
| Income tax | $m | [0.1](/filings/0001493152-24-044825.md) | [(0.3) d](/filings/0001641172-25-001819.md) | not reported | [0.0](/filings/0001641172-25-024022.md) | [0.0 d](/filings/0001493152-25-022351.md) | [(0.0) d](/filings/0001493152-26-013924.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.0)](/filings/0001493152-24-044825.md) | [(5.5) d](/filings/0001641172-25-001819.md) | [(7.2)](/filings/0001641172-25-009686.md) | [(4.3)](/filings/0001641172-25-024022.md) | [(7.7)](/filings/0001493152-25-022351.md) | [30.9 d](/filings/0001493152-26-013924.md) | [(6.6)](/filings/0001493152-26-023080.md) | [(8.2)](/filings/0001493152-26-037742.md) | [(4.7)](/filings/0001493152-25-022351.md) | [(1.8) d](/filings/0001493152-26-013924.md) | [(6.7)](/filings/0001493152-26-023080.md) | [(9.3)](/filings/0001493152-26-037742.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.4](/filings/0001493152-23-041312.md) | [6.1](/filings/0001641172-25-001819.md) | [5.5](/filings/0001493152-24-018807.md) | [17.5](/filings/0001493152-24-031651.md) | [16.7](/filings/0001493152-24-044825.md) | [20.4](/filings/0001493152-26-013924.md) | [19.6](/filings/0001641172-25-009686.md) | [17.1](/filings/0001641172-25-024022.md) | [15.1](/filings/0001493152-25-022351.md) | [13.2](/filings/0001493152-26-037742.md) | [12.2](/filings/0001493152-26-023080.md) | [9.6](/filings/0001493152-26-037742.md) |
| Total assets | $m | [43.5](/filings/0001493152-23-041312.md) | [43.0](/filings/0001641172-25-001819.md) | [40.9](/filings/0001493152-24-018807.md) | [37.7](/filings/0001493152-24-031651.md) | [34.2](/filings/0001493152-24-044825.md) | [72.0](/filings/0001493152-26-013924.md) | [68.6](/filings/0001641172-25-009686.md) | [63.5](/filings/0001641172-25-024022.md) | [61.5](/filings/0001493152-25-022351.md) | [63.7](/filings/0001493152-26-037742.md) | [57.5](/filings/0001493152-26-023080.md) | [50.8](/filings/0001493152-26-037742.md) |
| Total liabilities | $m | [4.1](/filings/0001493152-23-041312.md) | [5.7](/filings/0001641172-25-001819.md) | [7.4](/filings/0001493152-24-018807.md) | [5.1](/filings/0001493152-24-031651.md) | [6.0](/filings/0001493152-24-044825.md) | [1.9](/filings/0001493152-26-013924.md) | [1.6](/filings/0001641172-25-009686.md) | [1.7](/filings/0001641172-25-024022.md) | [1.9](/filings/0001493152-25-022351.md) | [3.2](/filings/0001493152-26-037742.md) | [1.2](/filings/0001493152-26-023080.md) | [1.3](/filings/0001493152-26-037742.md) |
| Shareholders' equity | $m | [39.0](/filings/0001493152-23-041312.md) | [37.3](/filings/0001641172-25-001819.md) | [33.8](/filings/0001493152-24-018807.md) | [33.0](/filings/0001493152-24-031651.md) | [29.0](/filings/0001493152-24-044825.md) | [70.2](/filings/0001493152-26-013924.md) | [67.1](/filings/0001641172-25-009686.md) | [61.9](/filings/0001641172-25-024022.md) | [59.7](/filings/0001493152-25-022351.md) | [60.7](/filings/0001493152-26-037742.md) | [56.3](/filings/0001493152-26-023080.md) | [49.6](/filings/0001493152-26-037742.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,440) d](/filings/0001493152-24-044825.md) | [(2,039) d](/filings/0001641172-25-001819.md) | [(2,259)](/filings/0001641172-25-009686.md) | [(4,210) d](/filings/0001641172-25-024022.md) | [(2,152) d](/filings/0001493152-25-022351.md) | [(417) d](/filings/0001493152-26-013924.md) | [(1,258)](/filings/0001493152-26-023080.md) | [(2,148) d](/filings/0001493152-26-037742.md) | [(1,918) d](/filings/0001493152-25-022351.md) | [(360) d](/filings/0001493152-26-013924.md) | [(2,945)](/filings/0001493152-26-023080.md) | [(2,595) d](/filings/0001493152-26-037742.md) |
| Capital expenditure | $k | [312 d](/filings/0001493152-24-044825.md) | [83.2 d](/filings/0001493152-24-012008.md) | [143](/filings/0001641172-25-009686.md) | [31.6 d](/filings/0001641172-25-024022.md) | [(74.5) d](/filings/0001493152-25-022351.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) |
| --- | --- | ---: |
| Diluted shares (weighted) | thousands of shares | [2,629](/filings/0001493152-23-030591.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,438,632 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037742.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.